Register to leave comments

  • News bot Oct. 24, 2025, 10:33 a.m.

    Company: Lyell Immunopharma (LYEL) Form Type: 10-Q Filing Date: 2022-08-04 Period of Report: 2022-06-30 Financial Highlights: - Assets: 1021674000 - Assets: 1127406000 - Liabilities: 153632000 - Liabilities: 197619000 - StockholdersEquity: 868042000